Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Taku, MIYOSHI"'
Autor:
Teruhiko Mizumoto, Yutaka Kakizoe, Terumasa Nakagawa, Yasunobu Iwata, Yoshikazu Miyasato, Kohei Uchimura, Masataka Adachi, Qinyuan Deng, Manabu Hayata, Jun Morinaga, Taku Miyoshi, Yuichiro Izumi, Takashige Kuwabara, Yoshiki Sakai, Kimio Tomita, Kenichiro Kitamura, Masashi Mukoyama
Publikováno v:
Journal of Pharmacological Sciences, Vol 146, Iss 4, Pp 192-199 (2021)
Metabolic syndrome (MetS) is associated with chronic kidney disease and proteinuria. Previously, we reported that a synthetic serine protease inhibitor, camostat mesilate (CM), mitigated hypertension and proteinuria in rodent disease models. The pres
Externí odkaz:
https://doaj.org/article/59eec7db31444310acc443e68816d53e
Autor:
Yutaka Kakizoe, Yoshikazu Miyasato, Tomoaki Onoue, Terumasa Nakagawa, Manabu Hayata, Kohei Uchimura, Jun Morinaga, Teruhiko Mizumoto, Masataka Adachi, Taku Miyoshi, Yoshiki Sakai, Kimio Tomita, Masashi Mukoyama, Kenichiro Kitamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 132, Iss 2, Pp 145-153 (2016)
Emerging evidence has suggested that aldosterone has direct deleterious effects on the kidney independently of its hemodynamic effects. However, the detailed mechanisms of these direct effects remain to be elucidated. We have previously reported that
Externí odkaz:
https://doaj.org/article/4f9c720a207e42d89d856d7808a43e91
Autor:
Yuki Narita, Miki Ueda, Kohei Uchimura, Yutaka Kakizoe, Yoshikazu Miyasato, Teruhiko Mizumoto, Jun Morinaga, Manabu Hayata, Terumasa Nakagawa, Masataka Adachi, Taku Miyoshi, Yoshiki Sakai, Daisuke Kadowaki, Sumio Hirata, Masashi Mukoyama, Kenichiro Kitamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 130, Iss 2, Pp 110-116 (2016)
We previously reported that camostat mesilate (CM) had renoprotective and antihypertensive effects in rat CKD models. In this study, we examined if CM has a distinct renoprotective effect from telmisartan (TE), a renin-angiotensin-aldosterone system
Externí odkaz:
https://doaj.org/article/a0568c95b4384664a6769932401155f7
Autor:
Jun Morinaga, Kimio Tomita, Yuichiro Izumi, Yasunobu Iwata, Teruhiko Mizumoto, Masashi Mukoyama, Yutaka Kakizoe, Takashige Kuwabara, Qinyuan Deng, Yoshiki Sakai, Terumasa Nakagawa, Yoshikazu Miyasato, Taku Miyoshi, Manabu Hayata, Kohei Uchimura, Kenichiro Kitamura, Masataka Adachi
Publikováno v:
Journal of Pharmacological Sciences, Vol 146, Iss 4, Pp 192-199 (2021)
Metabolic syndrome (MetS) is associated with chronic kidney disease and proteinuria. Previously, we reported that a synthetic serine protease inhibitor, camostat mesilate (CM), mitigated hypertension and proteinuria in rodent disease models. The pres
Autor:
Jun Morinaga, Tetsuya Tajiri, Kimio Tomita, Tatsuyuki Kakuma, Masataka Adachi, Kohei Uchimura, Hirotaka Fukami, Yuichiro Izumi, Teruhiko Mizumoto, Yutaka Kakizoe, Taku Miyoshi, Kenichiro Kitamura, Takashige Kuwabara, Manabu Hayata, Keishi Miyata, Haruki Horiguchi, Tsuyoshi Kadomatsu, Masashi Mukoyama, Yusuke Okadome, Saeko Tajiri, Michio Sato, Naoki Shiraishi, Taichi Sugizaki, Yuichi Oike
Publikováno v:
Nephrology Dialysis Transplantation. 35:854-860
Background Patients undergoing hemodialysis treatment have a poor prognosis, as many develop premature aging. Systemic inflammatory conditions often underlie premature aging phenotypes in uremic patients. We investigated whether angiopoietin-like pro
Autor:
Yusuke Hata, Yushi Nakayama, Taku Miyoshi, Daisuke Fujimoto, Hideki Inoue, Masataka Adachi, Ryosuke Irie, Takashige Kuwabara, Yutaka Kakizoe, Masashi Mukoyama
Publikováno v:
Nihon Naika Gakkai Zasshi. 106:2206-2213
Autor:
Yohei Misumi, Yukimasa Kohda, Ami Hamaguchi, Yu Nagayoshi, Yuichiro Izumi, Terumasa Nakagawa, Yukio Ando, Naomichi Matsumoto, Miyuki Nakagawa, Noriko Miyake, Ken Saida, Taku Miyoshi, Rei Miura, Masashi Mukoyama, Yutaka Kakizoe
Publikováno v:
CEN case reports. 9(1)
Alport syndrome (AS) is a rare hereditary disease that presents with chronic kidney disease and sensorineural hearing loss, and is diagnosed by its clinical features, pathological features on renal tissue, and mode of inheritance. We report a woman i
Autor:
Manabu Hayata, Teruhiko Mizumoto, Yoshikazu Miyasato, Kimio Tomita, Tomoaki Onoue, Yoshiki Sakai, Terumasa Nakagawa, Masataka Adachi, Jun Morinaga, Yutaka Kakizoe, Taku Miyoshi, Kohei Uchimura, Masashi Mukoyama, Kenichiro Kitamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 132, Iss 2, Pp 145-153 (2016)
Emerging evidence has suggested that aldosterone has direct deleterious effects on the kidney independently of its hemodynamic effects. However, the detailed mechanisms of these direct effects remain to be elucidated. We have previously reported that
Autor:
Yoshikazu Miyasato, Masataka Adachi, Yutaka Kakizoe, Jun Morinaga, Daisuke Kadowaki, Teruhiko Mizumoto, Yoshiki Sakai, Yuki Narita, Manabu Hayata, Miki Ueda, Masashi Mukoyama, Taku Miyoshi, Kenichiro Kitamura, Kohei Uchimura, Naoki Shiraishi
Publikováno v:
Nephron. 129:223-232
Background/Aims: We have so far demonstrated the renoprotective effect of camostat mesilate (CM) in 5/6 nephrectomized rats at least partly through its antioxidant effect. However, precise mechanisms were not fully clarified. Therefore, we now examin
Autor:
Kenichiro Kitamura, Taku Miyoshi
Publikováno v:
Nihon Naika Gakkai Zasshi. 103:1123-1129